This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Ophthalmology  • Ophthalmological Disorders  • Macular Disorders  • Retinal/ Chorioretinal Disorders  • Ophthalmological Procedures  • Ophthalmological Procedures, Other  • Randomized Controlled Trial  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Commentary by Emily Y. Chew, MD

JAMA. 2009;302(15):1693-1695.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ARCHIVES OF OPHTHALMOLOGY

A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 5

The SCORE Study Research Group*

*Authors/Writing Committee: Michael S. Ip, MD (Chair); Ingrid U. Scott, MD, MPH; Paul C. VanVeldhuisen, PhD; Neal L. Oden, PhD; Barbara A. Blodi, MD; Marian Fisher, PhD; Lawrence J. Singerman, MD; Michael Tolentino, MD; Clement K. Chan, MD; Victor H. Gonzalez, MD

Objective To compare the efficacy and safety of 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone with observation for eyes with vision loss associated with macular edema secondary to perfused central retinal vein occlusion (CRVO).

Methods Multicenter, randomized, clinical trial of 271 participants.

Main Outcome Measure Gain in visual acuity letter score . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?